rs1554603293
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_017780.4(CHD7):c.5404G>A(p.Gly1802Ser) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 14/24 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1802D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_017780.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- CHARGE syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, Broad Center for Mendelian Genomics, ClinGen, G2P
- hypogonadotropic hypogonadism 5 with or without anosmiaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hypogonadotropic hypogonadismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Kallmann syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Omenn syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHD7 | NM_017780.4 | c.5404G>A | p.Gly1802Ser | missense_variant, splice_region_variant | Exon 25 of 38 | ENST00000423902.7 | NP_060250.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CHD7 | ENST00000423902.7 | c.5404G>A | p.Gly1802Ser | missense_variant, splice_region_variant | Exon 25 of 38 | 5 | NM_017780.4 | ENSP00000392028.1 | ||
| CHD7 | ENST00000524602.5 | c.1717-13075G>A | intron_variant | Intron 2 of 4 | 1 | ENSP00000437061.1 | ||||
| CHD7 | ENST00000695853.1 | n.5404G>A | splice_region_variant, non_coding_transcript_exon_variant | Exon 25 of 37 | ENSP00000512218.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1439352Hom.: 0 Cov.: 25 AF XY: 0.00 AC XY: 0AN XY: 717226
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
CHARGE syndrome Pathogenic:1
A heterozygous missense variant was identified, NM_017780.3(CHD7):c.5404G>A in exon 25 of the CHD7 gene (chr8:61761713). This substitution is predicted to create an amino acid change from a glycine to a serine at amino acid position 1802, NP_060250.2(CHD7):p.(Gly1802Ser) and/or a splice site change leading to aberrant splicing (due to it's location at the last base of the exon). Further testing via RNA studies are required to confirm if splicing is altered. The glycine at this position has high conservation but is not situated in a known functional domain. In silico software predicts the missense variant to be disease causing, and potentially cause aberrant splicing. This variant has not been previously observed in our patient cohort, is not present in population databases and has not been reported in other clinical cases. Another variant at this position has previously been reported as pathogenic (Pauli et al 2012). Parental testing indicated that this variant was maternally inherited. The mother also has features of CHARGE syndrome. Based on current information, this variant has been classified as LIKELY PATHOGENIC.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at